134 related articles for article (PubMed ID: 24328557)
1. Blockage of STAT3 signaling pathway with a decoy oligodeoxynucleotide inhibits growth of human ovarian cancer cells.
Liu M; Wang F; Wen Z; Shi M; Zhang H
Cancer Invest; 2014 Jan; 32(1):8-12. PubMed ID: 24328557
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
3. Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells.
Zhang X; Liu P; Zhang B; Wang A; Yang M
Cancer Genet Cytogenet; 2010 Feb; 197(1):46-53. PubMed ID: 20113836
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
5. STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells.
Ma Y; Zhang X; Xu X; Shen L; Yao Y; Yang Z; Liu P
PLoS One; 2015; 10(4):e0124924. PubMed ID: 25923701
[TBL] [Abstract][Full Text] [Related]
6. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes.
Zhang X; Zhang J; Wei H; Tian Z
Oncol Rep; 2007 Jun; 17(6):1377-82. PubMed ID: 17487394
[TBL] [Abstract][Full Text] [Related]
7. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.
Gu J; Li G; Sun T; Su Y; Zhang X; Shen J; Tian Z; Zhang J
J Neurooncol; 2008 Aug; 89(1):9-17. PubMed ID: 18415045
[TBL] [Abstract][Full Text] [Related]
8. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
[TBL] [Abstract][Full Text] [Related]
9. STAT3 Decoy ODN Therapy for Cancer.
Sun X; Zhang J
Methods Mol Biol; 2015; 1317():167-83. PubMed ID: 26072408
[TBL] [Abstract][Full Text] [Related]
10. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.
Han Z; Feng J; Hong Z; Chen L; Li W; Liao S; Wang X; Ji T; Wang S; Ma D; Chen G; Gao Q
Biochem Biophys Res Commun; 2013 May; 435(2):188-94. PubMed ID: 23665025
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.
Sun X; Zhang J; Wang L; Tian Z
Cancer Lett; 2008 Apr; 262(2):201-13. PubMed ID: 18248786
[TBL] [Abstract][Full Text] [Related]
13. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
14. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
Lu JP; Sun H; Cao CC; Ou ZL
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3.
Li Q; Zhu J; Sun F; Liu L; Liu X; Yue Y
Int J Mol Med; 2011 Jul; 28(1):101-8. PubMed ID: 21399864
[TBL] [Abstract][Full Text] [Related]
16. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
Lui VW; Boehm AL; Koppikar P; Leeman RJ; Johnson D; Ogagan M; Childs E; Freilino M; Grandis JR
Mol Pharmacol; 2007 May; 71(5):1435-43. PubMed ID: 17325127
[TBL] [Abstract][Full Text] [Related]
18. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
19. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
Shen J; Li R; Li G
In Vivo; 2009; 23(2):237-43. PubMed ID: 19414409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]